RecruitingNCT04322734

Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders

Studying Mitochondrial disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Southwest Autism Research & Resource Center
Principal Investigator
Richard E Frye, MD, PhD
Autism Discovery & Treatment Foundation
Enrollment
500 enrolled
Eligibility
18 years · All sexes
Timeline
2023 – 2028

Study locations (2)

Collaborators

State University of New York - Downstate Medical Center

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04322734 on ClinicalTrials.gov

Other trials for Mitochondrial disease

Additional recruiting or active studies for the same condition.

See all trials for Mitochondrial disease →

← Back to all trials